ArticleHernia : the journal of hernias and abdominal wall surgery2026
Hernia recurrence after concomitant laparoscopic ventral hernia repair using intraperitoneal biologic mesh: a retrospective analysis.
Article in Hernia : the journal of hernias and abdominal wall surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeEvidence is compelling for the safety and acceptable short-term outcomes of concomitant bariatric surgery (BS) and laparoscopic ventral hernia repair (LVHR). No studies have examined patient characteristics that may guide selection between concomitant LVHR and staged operations in patients undergoing laparoscopic Roux-en-Y (LRNY) or sleeve gastrectomy (LSG).
methodsA retrospective analysis of patients with concomitant LRNY or LSG and LVHR from 2013–2015. The association of demographics, comorbidities, hernia characteristics, repair technique, and post-operative weight regain was assessed based on hernia recurrence.
resultsWe included 90 patients, stratified by hernia recurrence (yes: N = 30, 33.3%, no: N = 60, 66.7%). Median follow-up was equivalent (58.0 months vs. 55.5 months, p = 0.45). The recurrence group had higher rates of cardiovascular disease (CVD) (86.7% vs. 63.3%, p = 0.04), chronic obstructive pulmonary disease (COPD) (13.3% vs. 1.7%, p = 0.04), and prior ventral hernia repair (20.0% vs. 3.3%, p = 0.02) There was no difference in age, pre-operative BMI, defect size, hernia reducibility or use of mesh. Most LVHR (83.3%) recurred before achieving nadir weight. An exploratory decision tree analysis found an age threshold of 45.3 years for hernia recurrence, where frequency increases from 16.1% to 42.4%. Patients > 45.3 years had increased CVD (83.1% vs. 48.4%, p = 0.001) and hypertension (81.4% vs. 48.4%, p = 0.003), but a lower pre-surgery BMI (45.5 vs. 52.1, p = 0.01).
conclusionHernia recurrence after concomitant BS and LVHR is likely not associated with weight regain, as most patients recur before reaching nadir weight. However, older patients with CVD and prior ventral hernia repairs demonstrated higher recurrence rates and may warrant consideration of staged operations.
Indexed as
Identifiers
42047866What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.